31.05.2024 • NewsConocoPhillipsMarathon OilOil & Gas

ConocoPhillips to Acquire Marathon Oil

US oil and gas giant ConocoPhillips has reached a definitive agreement to acquire Marathon Oil for $22.5 billion, including net debt of $5.4 billion. The transaction, which is subject to the approval of Marathon Oil stockholders, regulatory clearance and other customary closing conditions, is expected to close in the fourth quarter of 2024.

Under the terms of the agreement, Marathon Oil shareholders will receive 0.2550 shares of ConocoPhillips common stock for each share of Marathon Oil common stock, representing a 14.7% premium to the closing share price of Marathon Oil on May 28, 2024, and a 16.0% premium to the prior 10-day volume-weighted average price, the companies said in a statement.

“This acquisition of Marathon Oil further deepens our portfolio and fits within our financial framework, adding high-quality, low cost of supply inventory adjacent to our leading US unconventional position,” said ConocoPhillips CEO Ryan Lance.

“When combined with the global ConocoPhillips portfolio, I’m confident our assets and people will deliver significant shareholder value over the long term,” said Lee Tillman, CEO of Marathon Oil.

Given the adjacent nature of the acquired assets and a common operating philosophy, ConocoPhillips expects to realize $500 million in cost and capital synergies within the first full year of closing. The identified savings will come from reduced general and administrative costs, lower operating costs and improved capital efficiencies, the company said.

© ConocoPhillips
© ConocoPhillips

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis